| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067514 Pyrimidine compounds |
| 06/27/2006 | US7067513 Phenylpiperazines |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067511 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease |
| 06/27/2006 | US7067510 5-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-5,11-dihydro-6-oxa-12-thia-dibenzo[a,f]azulen-2-ol; 13-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-7,13-dihydro-12-oxa-benzo[4,5]cyclohepta[1,2-a]naphthalen-3-ol or derivatives or salts; for alleviating symptoms of estrogen deprivation, including bone loss |
| 06/27/2006 | US7067509 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression |
| 06/27/2006 | US7067508 Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 06/27/2006 | US7067507 Macrocycles useful in the treatment of Alzheimer's disease |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | US7067505 Di-steroidal prodrugs of estradiol |
| 06/27/2006 | US7067504 Di-steroidal prodrugs of ethinyl estradiol |
| 06/27/2006 | US7067503 17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 06/27/2006 | US7067502 A medicament containing formoterol or its pharmaceutically acceptable salt and/or mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease |
| 06/27/2006 | US7067501 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 06/27/2006 | US7067500 Betaines as adjuvants to susceptibility testing and antimicrobial therapy |
| 06/27/2006 | US7067498 Feeding low viscosity fiber and starch hydrolyzates; antidiabetic agents |
| 06/27/2006 | US7067497 Inhibiting the division of a malignant mammalian cell and for modulating the effects of cellular aging |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067494 Antimitotic eleuthesides |
| 06/27/2006 | US7067493 Single dose azithromycin |
| 06/27/2006 | US7067489 Hematopoietic stimulation |
| 06/27/2006 | US7067483 Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin |
| 06/27/2006 | US7067479 Compositions with enhanced antimicrobial efficacy against E. coli |
| 06/27/2006 | US7067315 Parasiticides; immunoassays; microbiocides |
| 06/27/2006 | US7067304 Monascus purpureus mutants and their use in preparing fermentation products having blood pressure lowering activity |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067276 administering a cytotoxic compound of porphyrin complexed with a radioactive metal to a mammal; treating arteriosclerotic lesions; radioactive metal is cytotoxic to cells in and surrounding the plaque |
| 06/27/2006 | US7067262 Determination binding of gabapentin to cells |
| 06/27/2006 | US7067261 Methods and compositions for treatment of central nervous system disorders |
| 06/27/2006 | US7067256 Ribozyme mediated inactivation of the androgen receptor |
| 06/27/2006 | US7067158 Preparation for the relief of disease |
| 06/27/2006 | US7067155 contains at least one additional anti-inflammatory agent such as indomethacin or another nonsteroidal anti-inflammatory drug; for oral, topical or injection administration; humate is prehistoric |
| 06/27/2006 | US7067154 Pharmaceutical compositions containing Vitamin D and calcium, their preparation and therapeutic use |
| 06/27/2006 | US7067152 Multi component moisture triggered controlled release system that imparts long lasting cooling sensation on the target site and/or provides high impact fragrance or flavor burst |
| 06/27/2006 | US7067151 Core of active material overcoated with talc, sodium lauryl sulfate and film forming polymer mixture |
| 06/27/2006 | US7067149 Coated active materials; carrier mixtureof disintegrating agent, diluent , lubricant , flavors, coloring, sweetening and binder; compression |
| 06/27/2006 | US7067148 Levothyroxine sodium and liothyronine sodium in solid form with microcrystalline cellulose; treating hypothyroidism and thyroid hormone replacement therapy |
| 06/27/2006 | US7067144 Compositions and methods for systemic inhibition of cartilage degradation |
| 06/27/2006 | US7067143 Premixed amiodarone parenteral solution and method for making the same |
| 06/27/2006 | US7067139 Administering Product R, a peptide-nucleic acid preparation, to patients having rheumatoid arthritis; analgesics; antiinflammatory, -swelling, -arthritic agents |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067124 Protease composition and method for treating a digestive disorder |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/27/2006 | US7067116 Mixture of water soluble film forming polymer such as pullulan , dextromethorphan and an ion exchange resin such as Amberlite |
| 06/27/2006 | US7067115 Process and composition for high efficacy teeth whitening |
| 06/27/2006 | US7067114 Delivery of antihistamines through an inhalation route |
| 06/27/2006 | US7067113 Antiinflammatory agents; anticancer agents; congestive heart failure; genetic disorders; contacting with dpamine receptors; determination binding; calibration |
| 06/27/2006 | US7066184 use of selected uncharged and cationic benzotriazole UV absorbers in the cosmetic treatment of human hair for protection against UV radiation; have affinity for hair so stays for longer periods |
| 06/27/2006 | CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators |
| 06/27/2006 | CA2326710C New dihydrofuro-¬3,4-b|quinolein-1-ones derivatives, the procedure for preparing them and the pharmaceutical compositions that contain them |
| 06/27/2006 | CA2315784C Tts containing an antioxidant |
| 06/27/2006 | CA2253833C Derivatives of k5 polysaccharide having high anticoagulant activity |
| 06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/27/2006 | CA2184889C Chemical castration |
| 06/27/2006 | CA2175370C Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 06/24/2006 | CA2529265A1 Quinoline derivatives for the treatment of latent tuberculosis |
| 06/24/2006 | CA2494575A1 Compositions and methods for the treatment of osteoporosis |
| 06/24/2006 | CA2488807A1 White ointment |
| 06/22/2006 | WO2006066267A2 Cancer treatment method |
| 06/22/2006 | WO2006066260A2 Compositions of and methods for producing phosphorus-chiral monomers and oligomers |
| 06/22/2006 | WO2006066235A1 Combination therapy for treating heart disease |
| 06/22/2006 | WO2006066203A2 Small interfering rna (sirna) molecules for modulating superoxide dismutase (sod) |
| 06/22/2006 | WO2006066197A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | WO2006066183A2 Novel saframycin analogs as therapeutic agents |
| 06/22/2006 | WO2006066174A1 Thiazolopyridinone derivates as mch receptor antagonists |
| 06/22/2006 | WO2006066173A2 Novel mch receptor antagonists |
| 06/22/2006 | WO2006066172A1 Aminopyrimidine compounds and methods of use |
| 06/22/2006 | WO2006066121A2 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 06/22/2006 | WO2006066080A1 3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF |
| 06/22/2006 | WO2006066079A2 Pyridazinone compounds |
| 06/22/2006 | WO2006066070A2 Prodrug constructs of pyrimidinone compounds as calcilytics |
| 06/22/2006 | WO2006066067A2 Formulations of bisphosphonate drugs with improved bioavailability |
| 06/22/2006 | WO2006066020A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/22/2006 | WO2006066011A2 Compounds and compositions as modulators of steroidal receptors and calcium channel activities |
| 06/22/2006 | WO2006066006A2 Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof |
| 06/22/2006 | WO2006065968A2 The uses of estrogen beta agonists to treat cognitive diseases |
| 06/22/2006 | WO2006065946A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | WO2006065916A1 Method of treating dry eye disorders using 13(s)-hode and its analogs |
| 06/22/2006 | WO2006065894A2 Methods for inhibiting stat3 signaling in immune cells |
| 06/22/2006 | WO2006065888A2 Targeted iron chelator delivery system |
| 06/22/2006 | WO2006065881A2 Use of ribose to alleviate rhabdomyolysis and the side effects of statin drugs |
| 06/22/2006 | WO2006065872A1 Piperazinyl-pyridine analogues |
| 06/22/2006 | WO2006065870A2 Topical numbing composition for laser therapy |
| 06/22/2006 | WO2006065853A2 Crystalline forms of a factor xa inhibitor |
| 06/22/2006 | WO2006065828A2 Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 06/22/2006 | WO2006065814A1 Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation |
| 06/22/2006 | WO2006065794A1 Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| 06/22/2006 | WO2006065793A2 TREATMENT OF INTERSTITIAL CYSTITIS USING (6aR,10aR)-Δ8-TETRAHYDROCANNABINOL-11-OIC ACIDS |
| 06/22/2006 | WO2006065792A2 Treatment of interstitial cystitis using cannabinoid analogs |
| 06/22/2006 | WO2006065788A2 Novel muscarinic acetylcholine receptor antagonists |
| 06/22/2006 | WO2006065780A2 Combinations of therapeutic agents for treating cancer |
| 06/22/2006 | WO2006065755A2 Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists |
| 06/22/2006 | WO2006065743A2 Tetracylic bicyclolides |
| 06/22/2006 | WO2006065727A1 Enhanced occlusive effect photodynamic therapy |
| 06/22/2006 | WO2006065726A2 Process for preparing voriconazole |
| 06/22/2006 | WO2006065722A2 Compositions and methods for pulmonary conditions |